189 related articles for article (PubMed ID: 16763275)
41. Expanding role of the medical oncologist in the management of head and neck cancer.
Choong N; Vokes E
CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
[TBL] [Abstract][Full Text] [Related]
42. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
Awada A; Ismael G
Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?
Glynne-Jones R; Hoskin P
J Clin Oncol; 2007 Nov; 25(33):5281-6. PubMed ID: 18024876
[TBL] [Abstract][Full Text] [Related]
44. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
45. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Zuccaro G; Vargo JJ; Dumot JA; Carroll MA
Am J Clin Oncol; 2007 Apr; 30(2):172-80. PubMed ID: 17414467
[TBL] [Abstract][Full Text] [Related]
46. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
47. The chemoradiation paradigm in head and neck cancer.
Seiwert TY; Salama JK; Vokes EE
Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856
[TBL] [Abstract][Full Text] [Related]
48. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
[TBL] [Abstract][Full Text] [Related]
49. [Chemotherapy for head and neck cancer].
Kohno N; Kitahara S
Gan To Kagaku Ryoho; 2000 Feb; 27(2):177-82. PubMed ID: 10700887
[TBL] [Abstract][Full Text] [Related]
50. Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Cho YH; Lee SH; Kim DW; Wu HG; Hah JH; Rhee CS; Sung MW; Kim KH; Heo DS
Head Neck; 2008 Mar; 30(3):346-50. PubMed ID: 17972310
[TBL] [Abstract][Full Text] [Related]
51. The role of taxanes and targeted therapies in locally advanced head and neck cancer.
Specenier P; Vermorken JB
Curr Opin Oncol; 2007 May; 19(3):195-201. PubMed ID: 17414636
[TBL] [Abstract][Full Text] [Related]
52. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
[TBL] [Abstract][Full Text] [Related]
53. Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck.
Pignon JP; Syz N; Posner M; Olivares R; Le Lann L; Yver A; Dunant A; Lewin F; Dalley DN; Paccagnella A; Taylor SG; Domenge C; Bourhis J; Mazumdar M
Anticancer Drugs; 2004 Apr; 15(4):331-40. PubMed ID: 15057136
[TBL] [Abstract][Full Text] [Related]
54. The expanding role of systemic therapy in head and neck cancer.
Cohen EE; Lingen MW; Vokes EE
J Clin Oncol; 2004 May; 22(9):1743-52. PubMed ID: 15117998
[TBL] [Abstract][Full Text] [Related]
55. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
[TBL] [Abstract][Full Text] [Related]
56. [Systemic neoadjuvant chemotherapy in advanced head and neck tumors: a randomized study of the combination of 5-FU/carboplatin versus 5-FU/cisplatin].
Starr S
Strahlenther Onkol; 1996 Mar; 172(3):173-5. PubMed ID: 8721267
[No Abstract] [Full Text] [Related]
57. Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck.
Tulunay OE; Enamorado II; Kucuk O; Heilbrun LK; Otero JE; Korkmaz H; Blumberg R; Jacobs JR
Head Neck; 2007 Mar; 29(3):267-71. PubMed ID: 17163471
[TBL] [Abstract][Full Text] [Related]
58. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
Vokes EE; Haraf DJ; Kies MS
Semin Oncol; 2000 Aug; 27(4 Suppl 8):34-8. PubMed ID: 10952436
[TBL] [Abstract][Full Text] [Related]
59. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
60. Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.
Haddad RI; Wirth L; Posner MR
Expert Rev Anticancer Ther; 2003 Jun; 3(3):331-8. PubMed ID: 12820776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
